| Martin, Gilles G. (Eurofins 200701 CEO + founder) |
Chief Executive Officer (CEO) |
Eurofins (Group) |
France |
| Martin, Jacques-François (Parteurop Pharma 201602 President + Founder before Mymetics + Chiron Vaccines) |
Chief Executive Officer (CEO) |
Parteurop Pharma (FR) |
France |
| Martin, Javier (Genycell Biotech 201107 CEO) |
Chief Executive Officer (CEO) |
Genycell Biotech España S.L. |
Spain (España) |
| Martin, Keith (Apitope 201810 Non-Executive Director before 2006–201810 CEO RETIRED 10/18) |
Board member, non-executive |
Apitope (Group) |
United Kingdom (GB) |
| Martin, Kelly (Malin Corp 201508– CEO before Elan CEO) |
Chief Executive Officer (CEO) |
Élan (Group) |
Ireland, Republic of |
| Martin, Klaus (Topas Therapeutics 202008– CEO before Apobiologix + Polpharma Biologics + Sandoz Biopharmaceuticals) |
Chief Executive Officer (CEO) |
Topas Therapeutics GmbH |
Germany |
| Martin, Kurt (Hepacult 201104 Managing Director) |
Managing Director |
Hepacult GmbH |
Germany |
| Martin, Roland (Univ Zürich 201104– Professor + Head Dept Neuroimmunology at Univ Hospital Zürich before inims Hamburg) |
Professor |
University of Zurich (UZH) |
Switzerland |
| Martin-Garcia, Jesús (Eclosion 201207 General Partner + Founder + GeNeuro 201512 CEO) |
General Partner (venture partner) |
Eclosion S.A. |
Switzerland |
| Martínez, Héctor (Cellink 201908 CTO + Co-Founder) |
Chief Technology/Technical Officer (CTO) |
Bico (Group) |
Sweden |
| Martinez, Ignacio (Flagship Pioneering 201303– General Partner formerly Syngenta Ventures) |
Investment Manager |
Flagship Pioneering |
United States (USA) |
| Martinez-Davis, Maya (GSK 202001– President of GSK US Pharma joined 9/19 before Merck (DE) + Pfizer) |
President/Director/Head Business Group/Unit/Division |
GSK (Group) |
United Kingdom (GB) |
| Martins, Fabien (MFPL 201107 Managing Director) |
Managing Director |
Max F. Perutz Laboratories GmbH (MFPL) |
Austria |
| Martis, Remberto (LenioBio 202203 Managing Director (CEO) + Founder) |
Managing Director |
LenioBio GmbH |
Germany |
| Martyr, David (Tecan 201202–201903 announced CEO for 10/12 before Leica Microsystems RETIRED 4/19) |
Chief Executive Officer (CEO) |
Tecan (Group) |
Switzerland |
| Maruyama, Hisashi (Hitachi 201901 CEO of Hitachi Chemical Co. Ltd.) |
Chief Executive Officer (CEO) |
Showa Denko (SDK) (Group) |
Japan |
| Marx, Thomas (RheinCell Therapeutics 202106 Chief Commercial Officer joined 2019) |
Business Development Manager / Strategy Manager |
Catalent (Group) |
Germany |
| Marx, Uwe (TissUse GmbH 201002– Managing Director + TU Berlin 201004– before ProBioGen –200411 CSO) |
Chief Executive Officer (CEO) |
TissUse GmbH |
|
| Maschek, Uwe (MagForce 200705–200912 CEO resigned 12/09 before Cephalon GmbH 1997–2007 Managing Director) |
Chief Executive Officer (CEO) |
MagForce (Group) |
Germany |
| Mascher, Hermann (pharm-analyt 201202 CEO + founder) |
Chief Executive Officer (CEO) |
pharm-analyt Labor GmbH |
Austria |
| Maskos, Michael (Institut für Mikrotechnik Mainz GmbH 201109– Managing Director) |
Managing Director |
Fraunhofer (Group) |
Germany |
| Mason, Christopher E. (Cornell Univ 201606 Assoc Prof Institute for Computational Biomedicine at Weill Cornell Medicine) |
Professor |
Cornell University |
United States (USA) |
| Mason, Mike (Eli Lilly 202001– President of Lilly Diabets before SVP Lilly Connected Care + Insulins) |
President/Director/Head Business Group/Unit/Division |
Eli Lilly (Group) |
United States (USA) |
| Mason, Richard (JnJ 201511– Head Innovation Centre London before XO1 + BTG + 4-Antibody + Advent Venture Partners + CAT) |
President/Director/Head Business Group/Unit/Division |
Johnson & Johnson (JnJ) (Group) |
United Kingdom (GB) |
| Mason, William T. (Bill) (The Sage Group 201503 Head of Sage Europe) |
Consultant (economic/technology) |
Sage Group (Group) |
United Kingdom (GB) |
| Massari, Nate (Anjarium Biosciences 202207– CBO before Aytu BioPharma + Rumpus Therapeutics + JnJ + Endo Pharma) |
Chief Business Officer (CBO) |
Anjarium Biosciences AG |
Switzerland |
| Massera, Patricio (Asahi Glass 202108 CEO of AGC Biologics) |
Chief Executive Officer (CEO) |
Asahi Glass (AGC) (Group) |
United States (USA) |
| Massey, Ian (Synosis 200701– CEO before Roche Bioscience) |
Chief Executive Officer (CEO) |
Acorda Therapeutics (Group) |
United States (USA) |
| Massouras, Andreas (Saphetor SA 201604 CEO + Founder before Citigroup + Credit Suisse + Salomon Brothers) |
Chief Executive Officer (CEO) |
Saphetor S.A. (VarSome) |
Switzerland |
| Massuyeau, Laurent (Addex 200804–200909 Head Business Developm before Idenix RESIGNED 9/09 at Addex) |
Business Development Manager / Strategy Manager |
Addex (Group) |
Switzerland |
| Matchett, Geraldine (DSM 2022205 Co-CEO 201508 CFO) |
Chief Executive Officer (CEO) |
DSM (Group) |
Netherlands |
| Matentzoglu, Konstantin (Celonic 201711 CEO before Trenzyme GmbH 201202 Managing Director) |
Managing Director |
Celonic (Group) |
Switzerland |
| Mateus, Manel (Optimum Strategic Communications 201902) |
Public Relations Manager / Investor Relations Manager |
Optimum Strategic Communications |
United Kingdom (GB) |
| Matheis, Georg (Stimit AG 202104 Board Director) |
Board member, non-executive |
Dräger (Group) |
Switzerland |
| Mather, Simon (WestLB 200809 Analyst) |
Analyst (Financial / Industry) |
Portigon (Group) |
Germany |
| Mathers, Edward T. (Ed) (New Enterprise Associates 200808– before MedImmune) |
Partner (venture partner) |
New Enterprise Associates (NEA) |
United States (USA) |
| Mathew, Prasad (Bayer 201207 VP Global Medical Affairs Hematology at Bayer HealthCare) |
n. a. |
Bayer (Group) |
Germany |
| Mathias, Frank (Rentschler 201604– CEO before Medigene + Amgen GmbH + Servier DE + Hoechst) |
Managing Director |
Rentschler (Group) |
Germany |
| Mathis, Luc (Meiogenix 202112 CEO before Global Bioenergies + Calyxt + Cellectis Plant Sciences) |
Chief Business Officer (CBO) |
Meiogenix S.A.S. |
France |
| Mathisen, Svein (BioInvent 200510 CEO) |
Chief Executive Officer (CEO) |
BioInvent International AB (Nasdaq Stockholm: BINV) |
Sweden |
| Mathur, Supriya (Optimum Strategic Communications 201905 before Hume Brophy) |
Public Relations Manager / Investor Relations Manager |
Optimum Strategic Communications |
United Kingdom (GB) |
| Matillon, Valentin (Sophia Genetics 201801– CFO before Hobart Group + SITA + Electronic Arts + Hewlett-Packard Europe) |
Chief Financial Officer (CFO) |
Sophia Genetics (Group) |
Switzerland |
| Matis, Louis A. (Pieris 201508– Chief Development Officer before Alexion + CGI Pharmaceuticals) |
Chief Medical Officer (CMO) |
Pieris (Group) |
United States (USA) |
| Matlow, Stuart (Stu) (Thermo Fisher 201206 Public Relations Manager Chromatography + Mass Spectrometry before Agilent) |
Public Relations Manager / Investor Relations Manager |
Thermo Fisher (Group) |
United States (USA) |
| Matsumoto, Hiroshi (RIKEN 201910 President) |
President/Director/Head Business Group/Unit/Division |
RIKEN Research Cluster for Innovation (JP) |
Japan |
| Mattacchione, Anthony L. (Tony) (Albany Molecular 201804– before Bruker Corp CFO + EMD Millipore) |
Chief Financial Officer (CFO) |
Albany Molecular (AMRI) (Group) |
United States (USA) |
| Mattaj, Iain (EMBL 200811 Director General) |
President/Director/Head Business Group/Unit/Division |
EMBL (European Molecular Biology Laboratory) |
Germany |
| Matter, Alex (Singapore (govt) 201310 CEO ETC of A*STAR before Novartis Global Head Oncology Research) |
Chief Executive Officer (CEO) |
Singapore (govt) |
Singapore |
| Mattessich, Antony (Purdue Pharma 201612 Managing Director of Mundipharma International Ltd) |
Managing Director |
Purdue Pharma (Group) |
United Kingdom (GB) |
| Matthes, Thomas (Sloning 200705– CBO before Sigma-Aldrich SAFC Biosciences before CellSystems Biotechnologie GmbH) |
Chief Business Officer (CBO) |
MorphoSys (Group) |
Germany |
| Matthews, Keith, Chief (ICIF 202203 Chairman) |
Board member |
Indigenous Critical Infrastructure Fund Canada (ICIF) |
Canada |
| Matthews, Werner |
n. a. |
Sparkassen-Finanzgruppe (DE) [FICTIVE UNIT, NOT OFFICIAL GROUP!] (Group) |
Germany |
| Matthyssens, Gaston (Vesalius Biocapital 201006 Investment Manager) |
Managing Partner (investment firm) |
Vesalius Biocapital (Group) |
Luxembourg |
| Mattil, Evi (Cryo-Save 201302– Chief Commercial Officer before Amoena + IMS Health (DE) + Chiron Vaccines) |
Chief Commercial Officer (CCO) |
Cryo-Save AG (CH) |
Switzerland |
| Mattingly, Quincy |
Business Development Manager / Strategy Manager |
Elchrom Scientific AG |
Switzerland |
| Mattner, Frank (Affiris 201502– Supervisory Board Member before CSO + Co-founder) |
Supervisory Board Member |
Affiris GmbH |
Austria |
| Matuschek, Elke (Kompass PR 201204) |
Public Relations Manager / Investor Relations Manager |
Kompass PR Elke Matuschek |
Germany |
| Matushansky, Igor (Hookipa Biotech 201802 CMO) |
Chief Medical Officer (CMO) |
Hookipa (Group) |
Austria |
| Matyas, Viktor (Aignostics 202008 CEO) |
Chief Executive Officer (CEO) |
Aignostics GmbH |
Germany |
| Matysiak, Stefan (febit 200705 VP + General Manager) |
General Manager (management) |
Hummingbird Diagnostics GmbH |
Germany |
| Matzen, Thomas J. C. |
n. a. |
BioAgency AG |
Germany |
| Matzke, Alexandra (Amcure GmbH 201202– Managing Director + Co-founder) |
Managing Director |
Amcure GmbH |
Germany |
| Matzko, Matthias (Imaging Service AG 200906 CEO) |
Chief Executive Officer (CEO) |
Imaging Service AG |
Germany |
| Mauch, Herr (Intavis 200809) |
Sales Manager / Marketing Manager |
HB Technologies (Group) |
Germany |
| Mauch, Klaus (Insilico Biotechnology 2004 became CEO before founder) |
Chief Executive Officer (CEO) |
Yokogawa (Group) |
Germany |
| Mauch, Reiner (Schott 201310 Head of Business Development) |
Business Development Manager / Strategy Manager |
Schott (Group) |
Germany |
| Maucher, Lukas (SHS 202205– CFO before one of Big Four auditing firms in Germany) |
Chief Financial Officer (CFO) |
SHS Capital (Group) |
Germany |
| Maughan, Spencer (Finistere Partners 201502 Venture Partner before Venrock) |
Venture Partner |
Finistere Partners LLC (Finistere Ventures) |
United States (USA) |
| Mauntz, Manfred (CMC Instruments GmbH 201304 Managing Director) |
Managing Director |
CMC Instruments GmbH Meß-, Regel- und Analysetechnik |
Germany |
| Mauracher, Christoph (Sony 201207 Head of Sony DADC BioSciences) |
President/Director/Head Business Group/Unit/Division |
Stratec (Group) |
Austria |
| Maurel, Loïc (Diaxonhit 201212– CEO before ExonHit President Management Board + France Biotech 201508 Board) |
Chief Executive Officer (CEO) |
Eurobio Scientific (Group) |
France |
| Maurer, Hans H. (Saarland Univ 201003 Professor) |
Professor |
Saarland University (Universität des Saarlandes) |
Germany |
| Maurer, Johannes (ImaGenes –200803–200904– Director Genomic Products + Marketing) |
Sales Manager / Marketing Manager |
Source BioScience (Group) |
Germany |
| Maurer, Karl-Heinz (ABF 201101– BusDev AB Enzymes GmbH before Henkel KGaA Corporate Director Biotechnology) |
Business Development Manager / Strategy Manager |
ABF (Group) |
Germany |
| Maus, Marcela V. (Harvard Univ 201708 Assistant Prof of Medicine at Harvard Medical + Director at MGHCC) |
Professor |
Harvard University |
United States (USA) |
| Mauvernay, Rolland-Yves (Debiopharm 201301 President + Founder) |
President/Director/Head Business Group/Unit/Division |
Debiopharm (Group) |
Switzerland |
| Mauvernay, Thierry (Debiopharm 201306 Board Member) |
Board member |
Debiopharm (Group) |
Switzerland |
| Mavilio, Fulvio (French Myopathy Association 201512 Scientific Director at Généthon) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
French Myopathy Association (AFM) |
France |
| May, Klaus J. W. (Genomatix 200411) |
Sales Manager / Marketing Manager |
Genomatix Software (Group) |
Germany |
| May, Stephanie (Trophic Communications 201801 before MacDougall European Office) |
Public Relations Manager / Investor Relations Manager |
Trophic Communications GmbH |
Germany |
| May, Tobias (Inscreenex 201204 Managing Director) |
Managing Director |
Inscreenex GmbH |
Germany |
| May, Travis (Roivant Sciences 201709– CEO of Datavant before LiveRamp CEO) |
Chief Executive Officer (CEO) |
Roivant (Group) |
United States (USA) |
| Mayer, Doris (AstraZeneca –201301 CFO at AstraZeneca GmbH LEFT 1/13) |
Chief Financial Officer (CFO) |
AstraZeneca (Group) |
Germany |
| Mayer, Katja (Germany (govt) 201601 Project Manager GALS in Germany at German Entrepreneurship GmbH) |
business program (governmental) |
LMU Munich (Ludwig-Maximilians-Universität München, University of Munich) |
Germany |
| Mayer, Manuel (Eppendorf 2008 Project Manager Development Hamburg) |
Research & Development Manager |
Eppendorf (Group) |
Germany |
| Mayer, Matthias P. (Univ Heidelberg 201606 Professor at Centre for Molecular Biology (ZMBH)) |
n. a. |
University of Heidelberg (Ruperto Carola) |
Germany |
| Mayer, Michael (TechnoStart 201107 Managing Director) |
Managing Director |
TechnoStart (Group) |
Germany |
| Mayer, Robert (Medigene 201512– Senior Manager PR + IR before College Hill Life Sciences/Northbank Munich) |
Public Relations Manager / Investor Relations Manager |
Medigene (Group) |
Germany |
| Mayr, Andreas (Endress+Hauser 201606– Executive Board Member + Corp Director Marketing + Technology) |
Chief Technology/Technical Officer (CTO) |
Endress+Hauser (Group) |
Switzerland |
| Mayr, Andreas (Therapy Invest Group 2012 founder) |
Company Founder |
Therapy Invest Group (Group) |
Germany |
| Mayr-Harting, Lucia (Marinomed Biotech 202202 Public Relations) |
Public Relations Manager / Investor Relations Manager |
Marinomed Biotech AG (VSE: MARI) |
Austria |
| Mayrhofer, Hans (MayLab 200703 Managing Director + Founder) |
Managing Director |
MayLab Analytical Instruments GmbH |
Austria |
| Mayweg, Alexander (Alex) (Versant Ventures 202003 promoted to Managing Director joined 2016) |
Partner (venture partner) |
Versant Ventures |
Switzerland |
| Mazey, Kara (MacDougall 201804) |
Public Relations Manager / Investor Relations Manager |
MacDougall Advisors Inc. |
United States (USA) |
| Mazumdar-Shaw, Kiran (Biocon 201105 Managing Director + Founder) |
Managing Director |
Biocon (Group) |
India |
| McAdam, Michaela (Sartorius 201409 Marketing Communications Manager at TAP Biosystems) |
Sales Manager / Marketing Manager |
Sartorius (Group) |
United Kingdom (GB) |
| McAllister, Andres (Debiopharm 201306 CSO Resesearch + Evaluation) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
Debiopharm (Group) |
Switzerland |
| McBean, Sandy (RainDance 201311 General Manager of Commercial Operations EMEA) |
Commercial Manager_o |
Bio-Rad (Group) |
France |
| McCamish, Mark A. (Forty Seven 201705– CEO before Novartis/Sandoz + PDL Biopharma + Amgen + Abbott) |
Chief Executive Officer (CEO) |
Forty Seven Inc. |
United States (USA) |
| McCann, Corey (Pear Therapeutics 201812 CEO) |
Chief Executive Officer (CEO) |
Pear Therapeutics Inc. |
United States (USA) |
![[LSG] Life-Sciences-Germany.com - The Life Sciences Web Portal for German-speaking Europe](/images/basics/lsg-life-sciences-germany-portal-logo-2019.png){kind=logo}
1 2 3 ... 45 46 47 ... 81 82 83 
![Picture [iito] No Content Marketing 650x100px](/banner/iito-business-intelligence-20211013-650-100-summer-banner-series-no-content-marketing.jpg)
![Picture [iito] LSE iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20111029-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
![Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 120x600px](/banner/iito-20150801-120-600-lse-life-sciences-europe-com.jpg)
![Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 120x600px](/banner/iito-20181119-120-600-lsus-life-sciences-usa-com.jpg)
